Working… Menu

Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04944368
Recruitment Status : Active, not recruiting
First Posted : June 29, 2021
Last Update Posted : October 11, 2021
Vaxine Pty Ltd
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : July 19, 2021
Estimated Study Completion Date : December 15, 2021